Abstract
Female sexual dysfunction (FSD) represents an enigmatic yet complex set of disorders in this millennia, wherein significant changes have been implemented in defining, categorizing and managing these conditions. FSD is best viewed through a biopsychosocial modelled approach that integrates the ever-changing scenarios that can affect a woman’s health [1]. This includes a woman’s psychological issues, interpersonal factors, her current health status and other sociocultural factors. Women’s sexuality is highly complex and the association between various factors like society, family, relationship and health is strictly non-linear in nature [2]. A problem in any one of these areas can ultimately result in a sexual dysfunction. The aim of this chapter is to briefly overview the female sexual interest/arousal disorder and orgasmic disorder and also outline the management of the same. Female pain disorders now reclassified as the genito-pelvic pain disorder have been comprehensively reviewed separately in the textbook.
Keywords
- Female Sexual Dysfunction (FSD)
- Female Sexual Interest/arousal Disorder (FSIAD)
- Hypoactive Sexual Desire Disorder (HSDD)
- Female Orgasmic Disorder (FOD)
- Flibanserin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Althof S, Leiblum S, Chevret-Meason M, et al. Psychological and interpersonal dimensions of sexual function or dysfunction. J Sex Med. 2005;26:793–800.
Rosen RC, Barsky JL. Normal sexual response in women. Obstet Gynecol Clin N Am. 2006;33:515–26.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington, VA: American Psychiatric Publishing; 2013.
Sungur MZ, Gunduz A. A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges. J Sex Med. 2014;11(2):364–73.
Clayton AH, Hamilton DV. Female sexual dysfunction. Obstet Gynecol Clin. 2009;36(4):861–76.
Giles KR, McCabe MP. Conceptualizing women’s sexual function: linear vs. circular models of sexual response. J Sex Med. 2009;6(10):2761–71.
Masters WH, Masters VJ. Human sexual inadequacy. New York City, New York: Bantam Books; 1980.
Sarin S, Amsel RM, Binik YM. Disentangling desire and arousal: a classificatory conundrum. Arch Sex Behav. 2013;42:1079–100.
Graham CA, Brotto LA, Zucker KJ. Response to Balon and Clayton (2014): female sexual interest/arousal disorder is a diagnosis more on firm ground than thin air. Arch Sex Behav. 2014;43:1231–4.
Balon R, Clayton AH. Female sexual interest/arousal disorder: a diagnosis out of thin air. Arch Sex Behav. 2014;43:1227–9.
Bachmann GA, Leiblum S, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol. 1989;73(3 pt 1):425–7.
Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13(suppl 6):S1–4.
Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med. 1997;19:387–91.
Michael RT. Sex in America: a definitive survey. Boston: Little, Brown; 1994. p. 111–31.
Flynn KE, Reese JB, Jeffery DD, et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology. 2012;21:594–601.
Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–8.
Kontula O, Haavio-Mannila E. Sexual pleasures. Enhancement of sex life in Finland 1971–1992. Dartmouth (NH): Aldershot Publishing; 1995.
Rosen C, Brown J, Heiman S, Leiblum C, Meston R, Shabsigh D, Ferguson R, D'Agostino R. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.
Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med. 2002;11(3):277–89.
Flynn KE, Lin L, Cyranowski JM, et al. Development of the NIH PROMIS® sexual function and satisfaction measures in patients with cancer. J Sex Med. 2013;10:43–52.
Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician. 2000;62(1):127–48.
Meston C, Buss D. Why women have sex: sexual motivation from adventure to revenge—and everything in between. London: The Bodley Head; 2009.
Clayton AH, Juarez EM. Female sexual dysfunction. Psychiatr Clin. 2017;40(2):267–84.
Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L. Female sexual dysfunction—medical and psychological treatments, committee 14. J Sex Med. 2017;14(12):1463–91.
Graziottin A, Leiblum SR. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med. 2005;2(s3:133–45.
Rowland DL, Kolba TN. Understanding orgasmic difficulty in women. J Sex Med. 2016;13(8):1246–54.
Clark L. Is there a difference between a clitoral and a vaginal orgasm? J Sex Res. 1970;6(1):25–8.
Barbach LG. Group treatment of preorgasmic women. J Sex Marital Ther. 1974;1:139–45.
Wylie K, Levin R, Hallam-Jones R, et al. Sleep exacerbation of persistent sexual arousal syndrome in a postmenopausal woman. J Sex Med. 2006;3:296–302.
Komisaruk BR, Whipple B, Crawford A, et al. Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res. 2004;1024:77–88.
Bradford A. Inhibited sexual desire in women. In: Grossman L, Walfish R, editors. Translating psychological research into practice. New York: Springer; 2014. p. 515–8.
Nairne KD, Hemsley DR. The use of directed masturbation training in the treatment of primary anorgasmia. Br J Clin Psychol. 1983;22:283–94.
Riley AJ, Riley EJ. A controlled study to evaluate directed masturbation in the management of primary orgasmic failure in women. Br J Psychiatry. 1978;133:404–9.
American Psychiatric Association. Training in and dissemination of empirically-validated psychological treatments: report and recommendations. Clin Psychol. 1995;48:3–24.
Schick V, Herbenick D, Rosenberger JG, et al. Prevalence and characteristics of vibrator use among women who have sex with women. J Sex Med. 2011;8:3306–15.
Melnik T, Hawton K, McGuire H. Interventions for vaginismus. Cochrane Database Syst Rev. 2012;12:CD001760.
Davis SR, Worsley R, Miller KK, et al. Androgens and female sexual function and dysfunction- findings from the fourth international consultation of sexual medicine. J Sex Med. 2016;13(2):168–78.
Bachmann GA, Komi JO. Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause. 2010;17(3):480–6.
Gao Z, Yang D, Yu L, et al. Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis. J Sex Med. 2015;12:2095–104.
Berman JR, Berman LA, Toler SM, et al. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind placebo controlled study. J Urol. 2003;170(6 Pt 1):2333–8.
Basson R, McInnes R, Smith MD, et al. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11(4):367–77.
Caruso S, Intelisano G, Lupo L, et al. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo controlled study. BJOG. 2001;108(6):623–8.
Ito TY, Polan ML, Whipple B, et al. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. J Sex Marital Ther. 2006;32(5):369–78.
Magon N, Kalra S. The orgasmic history of oxytocin: love, lust and labor. Indian J Endocrinol Metab. 2011;15(Suppl 3):S156–61.
Behnia B, Heinrichs M, Bergmann W, et al. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Horm Behav. 2014;65:308–18.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lakshmi, M., Khan, S.D. (2019). Female Sexual Dysfunction. In: Gunasekaran, K., Khan, S. (eds) Sexual Medicine . Springer, Singapore. https://doi.org/10.1007/978-981-13-1226-7_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-1226-7_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1225-0
Online ISBN: 978-981-13-1226-7
eBook Packages: MedicineMedicine (R0)